UBS Group
DXCM icon

UBS Group’s DexCom DXCM Stock Holding History

UBS Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1M Sell
494,800
-107,900
-18% -$7.51M ﹤0.01% 2131
2025
Q4 		$40M Sell
602,700
-73,600
-11% -$4.76M 0.01% 1858
2025
Q3 		$45.5M Buy
676,300
+382,200
+130% +$30.2M 0.01% 1727
2025
Q2 		$25.7M Sell
294,100
-86,500
-23% -$6.78M ﹤0.01% 2117
2025
Q1 		$26M Sell
380,600
-132,400
-26% -$10.8M ﹤0.01% 2102
2024
Q4 		$39.9M Sell
513,000
-38,300
-7% -$2.84M 0.01% 1655
2024
Q3 		$37M Buy
551,300
+266,100
+93% +$21.9M 0.01% 1373
2024
Q2 		$32.3M Buy
285,200
+50,700
+22% +$6.41M 0.01% 1332
2024
Q1 		$32.5M Buy
234,500
+66,000
+39% +$8.3M 0.01% 1341
2023
Q4 		$20.9M Sell
168,500
-28,500
-14% -$2.91M 0.01% 1550
2023
Q3 		$18.4M Buy
197,000
+69,900
+55% +$7.88M 0.01% 1548
2023
Q2 		$16.3M Buy
127,100
+64,800
+104% +$7.84M 0.01% 1602
2023
Q1 		$7.24M Buy
62,300
+61,078
+4,998% +$6.84M ﹤0.01% 2171
2022
Q4 		$138K Sell
1,222
-48,778
-98% -$5.36M ﹤0.01% 5788
2022
Q3 		$4.03M Buy
+50,000
New +$4.23M ﹤0.01% 2554
2021
Q3 		– Sell
-20,000
Closed -$2.13M – 9651
2021
Q2 		$2.13M Sell
20,000
-40,000
-67% -$3.84M ﹤0.01% 3521
2021
Q1 		$5.39M Buy
+60,000
New +$5.63M ﹤0.01% 2516
2020
Q3 		– Sell
-36,000
Closed -$3.65M – 8067
2020
Q2 		$3.65M Buy
+36,000
New +$3.22M ﹤0.01% 2312
2019
Q4 		– Sell
-20,800
Closed -$776K – 8162
2019
Q3 		$776K Buy
+20,800
New +$808K ﹤0.01% 4187
2019
Q2 		– Sell
-33,600
Closed -$1M – 7918
2019
Q1 		$1M Buy
+33,600
New +$1.18M ﹤0.01% 3592

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UBS Group's DXCM Position: Q1 2026 in Review

UBS Group increased its DexCom (DXCM) stake by 126% in Q1 2026, buying an estimated $169M and bringing the position to 4,349,959 shares worth $273M. The position accounts for 0.04% of the portfolio, ranked #471.

UBS Group first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • UBS Group held 4,349,959 shares of DexCom worth $273M as of Q1 2026.
  • UBS Group bought 2,426,179 DexCom shares in Q1 2026, an estimated $169M.
  • DexCom made up 0.04% of UBS Group's portfolio in Q1 2026, its #471 holding.
  • UBS Group first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.